Delivery Order SPE2DB20D1100-SPE2DB24FE0S1
Award Date
9/27/24
Potential Completion Date
10/21/24
Potential Value
$231K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The contract, valued at $46,236.16, is a Delivery Order from the Defense Logistics Agency (DLA) to provide OCREVUS 300 MG/10 ML VIAL 10ML. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a...
This is a delivery order award to AmerisourceBergen Drug Corp's Corporate Office Division by the Medical Supply Chain, a component of the Defense Logistics Agency (DLA) Troop Support. The $46,236.16 firm fixed-price contract is for the supply of 4,565,698,031 units of the pharmaceutical product OCREVUS 300 MG/10 ML VIAL 10ML. The contract has a completion date of September 26, 2024. AmerisourceBergen, one of the largest pharmaceutical distributors in the U.S., provides a wide range of medical...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract valued at $23,118.08 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution company. The contract is for the supply of OCREVUS 300 MG/10 ML VIAL 10ML, a specialty pharmaceutical product. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of OCREVUS 300 MG/10 ML VIAL 10ML, a prescription pharmaceutical product. The contract has a value of $115,590.40 and a completion date of September 25, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this contract to provide the specified medication to...
Amerisourcebergen Drug Corp, a pharmaceutical distribution company, was awarded a firm fixed price delivery order by the Defense Logistics Agency (DLA) Troop Support Medical valued at $23,118.08. The order is for the supply of OCREVUS 300 MG/10 ML VIAL 10ML, a specialty pharmaceutical product, with a completion date of February 26, 2024. Amerisourcebergen Drug Corp has previously received numerous federal contract awards from DLA to provide a range of pharmaceutical and medical supplies in...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The $57,795.20 firm-fixed-price contract is for the supply of OCREVUS 300 MG/10 ML VIAL 10ML, a specialty pharmaceutical product. The contract has an ultimate completion date of October 7, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this contract to provide this critical medication to support various government agencies...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $60,096.40, is for the delivery of OCREVUS 300 MG/10 ML VIAL 10ML, a specialty medication. The contract has a fixed price and a completion date of February 18, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of OCREVUS 300 mg/10 ml vials. The contract is a delivery order valued at $115,590.40 with a completion date of October 30, 2024. It is not set aside for any specific business type. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with DLA Troop Support Medical and the Department of Justice Federal Bureau of...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation's Corporate Office division. The $34,677.12 firm fixed price contract is for the supply of OCREVUS 300 mg/10 ml vials, which are used for the treatment of multiple sclerosis. The contract has an ultimate completion date of September 27, 2024 and does not have a set-aside designation. As a major pharmaceutical distributor, AmerisourceBergen holds...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of various pharmaceutical products and medical supplies. The contract has a ceiling value of $17,040.18 and a period of performance through August 1, 2024. AmerisourceBergen is an experienced federal contractor, holding several Indefinite Delivery Contracts (IDCs) with the DLA and Department of Justice, valued up to...